- Report
- March 2024
- 90 Pages
Africa, Middle East
From €3293EUR$3,450USD£2,759GBP
- Report
- March 2024
- 100 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- March 2024
- 104 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- March 2024
- 101 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2023
- 200 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- August 2022
- 118 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2021
- 99 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 210 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- May 2022
- 84 Pages
Europe
From €3579EUR$3,750USD£2,999GBP
- Report
- May 2022
- 95 Pages
Asia Pacific
From €3579EUR$3,750USD£2,999GBP
- Report
- April 2022
- 80 Pages
United States
From €3197EUR$3,350USD£2,679GBP
- Report
- April 2022
- 95 Pages
North America
From €3579EUR$3,750USD£2,999GBP
- Report
- February 2024
- 288 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Drug Pipelines
- January 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1432EUR$1,500USD£1,199GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more